Murdo Gordon
Net Worth
Last updated:
What is Murdo Gordon net worth?
The estimated net worth of Mr. Murdo Gordon is at least $21,445,505 as of 10 Aug 2023. He owns shares worth $13,177,199 as insider, has earned $2,508,306 from insider trading and has received compensation worth at least $5,760,000 in Amgen Inc..
What is the salary of Murdo Gordon?
Mr. Murdo Gordon salary is $2,880,000 per year as Executive Vice President of Global Commercial Operations in Amgen Inc..
How old is Murdo Gordon?
Mr. Murdo Gordon is 58 years old, born in 1967.
What stocks does Murdo Gordon currently own?
As insider, Mr. Murdo Gordon owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Amgen Inc. (AMGN) | Executive Vice President of Global Commercial Operations | 44,308 | $297.4 | $13,177,199 |
What does Amgen Inc. do?
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Murdo Gordon insider trading
Amgen Inc.
Mr. Murdo Gordon has made only one insider trade in 2023, according to the Form 4 filled with the SEC. He sold 9,558 units of AMGN stock worth $2,508,306 on 10 Aug 2023.
As of 10 Aug 2023 he still owns at least 44,308 units of AMGN stock.
Amgen key executives
Amgen Inc. executives and other stock owners filed with the SEC:
- Dr. David M. Reese M.D. (62) Executive Vice President of R&D
- Mr. Esteban Santos (57) Executive Vice President of Operations
- Mr. Murdo Gordon (58) Executive Vice President of Global Commercial Operations
- Mr. Peter H. Griffith (66) Executive Vice President & Chief Financial Officer
- Mr. Robert A. Bradway (62) Chairman, Chief Executive Officer & Pres